Oaktree Fund Advisors, LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 9 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Oaktree Fund Advisors, LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$23,760
-59.4%
66,0000.0%0.02%
-74.7%
Q4 2022$58,476
-43.2%
66,0000.0%0.09%
-45.6%
Q3 2022$103,000
-22.0%
66,0000.0%0.16%
-31.0%
Q2 2022$132,000
+13.8%
66,000
+32.0%
0.23%
+22.8%
Q1 2022$116,000
-50.0%
50,0000.0%0.19%
-60.2%
Q4 2021$232,000
-53.9%
50,000
-24.2%
0.48%
-99.0%
Q3 2021$503,000
-21.4%
66,0000.0%48.93%
-19.6%
Q2 2021$640,00066,00060.89%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,711,063$14,355,0005.36%
Avoro Capital Advisors LLC 2,151,437$18,051,0004.69%
Cormorant Asset Management, LP 2,095,334$17,580,0002.81%
ACUTA CAPITAL PARTNERS, LLC 300,000$2,517,0001.46%
AlpInvest Partners B.V. 86,540$726,0001.43%
Healthcare Value Capital, LLC 50,000$420,0000.60%
Aisling Capital LLC 353,855$2,969,0000.52%
CAPITAL MANAGEMENT ASSOCIATES /NY/ 20,000$168,0000.26%
HAMILTON LANE ADVISORS LLC 51,582$433,0000.21%
Spark Investment Management LLC 106,400$891,0000.12%
View complete list of SORRENTO THERAPEUTICS INC shareholders